3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
26
Triple Negative Breast Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Adenocarcinoma of Lung
3
Rectal Neoplasms
2
Solitary Pulmonary Nodule
1
Pain, Postoperative
1
Lymphedema
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Breast Cancer Female
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Radiotherapy
2
Paclitaxel
2
Carboplatin
2
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Trastuzumab
1
Taxes
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiation
1
Mastectomy, Segmental
1
Mastectomy
1
Mass Spectrometry
1
Immunohistochemistry
1
Gene Expression Profiling
1
Fulvestrant
1
Fluorescent Antibody Technique
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Counseling
1
Chromatography, Liquid
1
Brachytherapy
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Mastectomy, Segmental
×
1 year
×
Clear all
NCT03909282
2026-03-12
NORDIS
Stanford University
Phase NA
Recruiting
50 enrolled